AN0025, a novel antagonist of PGE2-receptor E-type 4 (EP4), in combination with total neoadjuvant treatment of advanced rectal cancer
Lucjan Wyrwicz, Mark Saunders, Marcia Hall, John Ng, Theodore S. Hong, Ying Xu, Justin Lucas, Xuyang Lu, Nathan J. Lautermilch, Silvia C. Formenti, Rob Glynne‐Jones
Topics & Concepts
MedicineAdverse effectRadiation therapyChemotherapyStage (stratigraphy)Colorectal cancerInternal medicineSurgeryCancerPathologicalMagnetic resonance imagingRadiologyPaleontologyBiologyColorectal Cancer Surgical TreatmentsInflammatory mediators and NSAID effectsTGF-β signaling in diseases